At each stage of the development process, from concept through delivery, we are committed to ensuring our devices and molecular technologies meet end-user needs and improve patient outcomes.
Our team of scientists, molecular biologists, engineers, and experts focus on developing patented and clinically proven molecular technologies for the early detection of HR-HPV and respiratory viruses.
We identify the need and market opportunity.
We define characteristics and applications to create patentable differentiating molecular technologies that will empower people.
We design and develop medical devices and molecular technologies that help enhance quality of life.
Our devices are manufactured in strict compliance with all applicable standards and are validated through preclinical and clinical trials before being launched on the market.
We monitor results and mitigate risks and request the relevant regulatory authorizations.
We penetrate the market and deliver first-rate follow-up for our medical devices and molecular technologies (techno-surveillance).
Because our commercial partners are vital to our growth, at Mel-Mont Medical we have built strategic commercial alliances with organizations in Europe and Latin America to share our experience and know-how.
We work to deliver safe and reliable, patented molecular biology technologies for our clients and users.
Have Questions? Our team is happy to answer any questions you may have.
